Quinta-Analytica s.r.o
Quinta-Analytica s.r.o is recorded as a service provider in 5 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 5 of 5 trials · Latest update first
PACIFICA Phase 3: A Randomized, Controlled Phase 3 Study of Pacritinib Versus Physician’s Choice in Patients with Primary Myelofibrosis, Post Polycythemia Vera Myelofibrosis, or Post Essential Thrombocythemia Myelofibrosis with Severe Thrombocytopenia (Platelet Counts <50,000/μL)
Sponsor Sobi Inc.
- Start (EU)
- Latest update
- Estimated end
A Multicenter, Randomized, Double-Blind, Double-Dummy, Phase III Study to Evaluate the Efficacy and Safety of Letrozole SIE Compared to Femara® (both in Combination with the CDK4/6 Inhibitor Ribociclib) in Postmenopausal Women with HR-Positive, HER2-Negative, Inoperable Locally Advanced or Metastatic Breast Cancer (SIE-3)
Sponsor Laboratorios Farmaceuticos Rovi S.A.
- Start (EU)
- Not reported
- Latest update
- Estimated end
PAXIS: A randomized, double-blind, placebo-controlled dose-finding phase 2 study (Part 1) followed by an open-label period (Part 2) to assess the efficacy and safety of pacritinib in patients with VEXAS syndrome
Sponsor Sobi Inc.
- Start (EU)
- Latest update
- Estimated end
Pharmacokinetic Study of Single and Multiple Dose of PKL-021 Administered Orally to Healthy Subjects
Sponsor Pikralida Sp. z o.o.
- Start (EU)
- Latest update
- Estimated end
- Not reported
A multicentric phase 1/2 trial to evaluate the safety and efficacy of SOT102 as monotherapy and in combination with standard of care treatment in patients with gastric and pancreatic adenocarcinoma
Sponsor SOTIO Biotech a.s.
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Quinta-Analytica s.r.o?
The 2026-10-09 snapshot links Quinta-Analytica s.r.o to 5 distinct CTIS trials. Recorded services include Laboratory services, ADA/PK analyses, Data management, Electronic data capture, among 13 recorded service labels. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Quinta-Analytica s.r.o?
The most frequently recorded therapeutic areas are Haematological Malignancies, Solid Tumor Oncology. Recorded phases include Phase 3. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Quinta-Analytica s.r.o conducted?
The linked trials record locations in 13 countries, including Czechia, Spain, France, Bulgaria, Italy. These are trial locations, not confirmed office locations or countries where Quinta-Analytica s.r.o delivered services.
What can this page tell me about Quinta-Analytica s.r.o's trial experience?
Browse 5 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Quinta-Analytica s.r.o. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Quinta-Analytica s.r.o.